Nasus Pharma Ltd. (NSRX)
NSRX Stock Price Chart
Explore Nasus Pharma Ltd. interactive price chart. Choose custom timeframes to analyze NSRX price movements and trends.
NSRX Company Profile
Discover essential business fundamentals and corporate details for Nasus Pharma Ltd. (NSRX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
13 Aug 2025
Employees
7.00
Website
https://www.nasuspharma.comCEO
Dan Teleman
Description
Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel.
NSRX Financial Timeline
Browse a chronological timeline of Nasus Pharma Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 1 Jul 2026
NSRX Stock Performance
Access detailed NSRX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
